MedPath
FDA Approval

DIPHENHYDRAMINE HCI

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Effective Date
February 19, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Diphenhydramine(50 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

HF Acquisition Co LLC, DBA HealthFirst

045657305

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

HF Acquisition Co LLC, DBA HealthFirst

HF Acquisition Co LLC, DBA HealthFirst

HF Acquisition Co LLC, DBA HealthFirst

045657305

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIPHENHYDRAMINE HCI

Product Details

NDC Product Code
51662-1218
Application Number
ANDA040140
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
February 19, 2020
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: TC2D6JAD40Class: ACTIBQuantity: 50 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath